US Stock MarketDetailed Quotes

AVBP ArriVent BioPharma

Watchlist
  • 27.470
  • +0.880+3.31%
Trading Nov 22 15:40 ET
925.66MMarket Cap-11422P/E (TTM)

About ArriVent BioPharma Company

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Company Profile

SymbolAVBP
Company NameArriVent BioPharma
Listing DateJan 26, 2024
Issue Price18.00
Founded2021
CEODr. Zhengbin Yao, PhD
MarketNASDAQ
Employees40
Fiscal Year Ends12-31
Address18 Campus Boulevard,Suite 100
CityNewtown Square
ProvincePennsylvania
CountryUnited States of America
Zip Code19073
Phone1-628-277-4836
Websitehttp://www.arrivent.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Zhengbin Yao, PhD
  • Chairman of Board and Chief Executive Officer
  • 1.19M
  • Robin LaChapelle, M.D.
  • Chief Operating Officer
  • 960.99K
  • Winston Kung, M.B.A.
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • --
  • Dr. Stuart Lutzker, M.D.,PhD
  • Director and President, Research and Development
  • 828.75K
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Director
  • --
  • Dr. Bahija Jallal, PhD
  • Independent Director
  • 17.80K
  • Dr. John A. Hohneker, M.D.
  • Independent Director
  • --
  • Dr. James I. Healy, M.D.,PhD
  • Independent Director
  • --
  • Kristine Peterson
  • Independent Director
  • --
  • Christian W. Nolet, C.P.A.
  • Independent Director
  • 79.28K
  • James Paul Kastenmayer, J.D.,PhD
  • General Counsel and Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data